Search results
Denali Therapeutics Inc. (DNLI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2...
Zacks via Yahoo Finance· 2 years agoDenali Therapeutics Inc. (DNLI) possesses the right combination of the two key ingredients for a...
Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoDenali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of 7.69% and 15.73%,...
Denali Therapeutics Inc. (DNLI) Moves 17.7% Higher: Will This Strength Last?
Zacks via Yahoo Finance· 2 years agoDenali Therapeutics Inc. (DNLI) saw its shares surge in the last session with trading volume being...
Why Is Denali Therapeutics Inc. (DNLI) Down 16% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Denali Therapeutics Inc. (DNLI). Shares...
With 63% ownership, Denali Therapeutics Inc. (NASDAQ:DNLI) boasts of strong institutional backing
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Denali Therapeutics Inc. (NASDAQ:DNLI) should be aware of the most powerful...
Denali Therapeutics Inc (DNLI) Reports Full Year and Q4 2023 Financial Results
GuruFocus.com via Yahoo Finance· 3 months agoNet Loss: Reported a net loss of $119.5 million for Q4 and $145.2 million for the full year 2023....
Is There An Opportunity With Denali Therapeutics Inc.'s (NASDAQ:DNLI) 50% Undervaluation?
Simply Wall St. via Yahoo Finance· 3 weeks agoKey Insights Using the 2 Stage Free Cash Flow to Equity, Denali Therapeutics fair value estimate is...
After losing 39% in the past year, Denali Therapeutics Inc. (NASDAQ:DNLI) institutional owners must...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Given the large stake in the stock by institutions, Denali Therapeutics' stock price...
Pinning Down Denali Therapeutics Inc.'s (NASDAQ:DNLI) P/S Is Difficult Right Now
Simply Wall St. via Yahoo Finance· 9 months agoThere wouldn't be many who think Denali Therapeutics Inc.'s (NASDAQ:DNLI) price-to-sales (or "P/S")...